HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Mepivacaine Hydrochloride

HCID 66070
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1722-62-9
Standard SMILES
Cc1cccc(C)c1NC(=O)C1CCCCN1C.Cl
InChIKey
RETIMRUQNCDCQB-UHFFFAOYSA-N
Molecular formula
C15H23ClN2O
Average molar mass
282.81 g/mol
Monoisotopic mass
282.14989104

Overview

Mepivacaine hydrochloride is the hydrochloride salt of mepivacaine. It is used as a local anaesthetic. It has a role as a local anaesthetic. It is a hydrochloride and a piperidinecarboxamide. It is functionally related to a mepivacaine.

Names & identifiers

Preferred name
Mepivacaine Hydrochloride
IUPAC
N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide;hydrochloride
English name
Mepivacaine hydrochloride
Molecular formula
C15H22N2O.ClH
Molecular weight
282.81

Names & synonyms

Mepivacaine hydrochloride1722-62-9Mepivacaine HCLScandicainOptocainScandonest PlainPolocaine-MpfArestocaine hydrochlorideMepivacaine MonohydrochlorideISOCAINE HYDROCHLORIDE1-Methyl-2',6'-pipecoloxylidide hydrochloride1-Methyl-2',6'-pipecoloxylidide monohydrochloride
Show more names
N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide hydrochlorideMepivacaine ImpurityMeaverinMepidentMepicatonChlorocainCarbocainaScandonest
4VFX2L7EM5NSC-758674(1-Methyl-DL-piperidine-2-carboxylic acid)-2,6-dimethylanilide hydrochlorideCHEBI:67602-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-, hydrochloride (1:1)N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide hydrochloride (1:1)Iq Dental MepivacaineScandonest 3% Plain

Database identifiers

CAS
1722-62-9

Properties

Computed structural properties

Topological polar surface area
32.3 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
2
Rotatable bonds
2
Heavy atoms
19
Formal charge
0
Complexity
282

Experimental & physicochemical properties

Solubility>42.4 [ug/mL] (The mean of the results at pH 7.4)
Human Drugs · 3 items

Breast Feeding; Lactation; Anesthetics, Local

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Animal Drugs · 2 items

Active Ingredients (Mepivacaine Hydrochloride) -> FDA Greenbook

Pharmaceuticals -> UK Veterinary Medicines Directorate List

Collision Cross Section157.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
255 · 255-257°C (dec.)
storage temp.
2 · 2-8°C
solubility
2 O: · H2O: soluble20mg/mL, clear
form
powder
color
white to beige
Water Solubility
2 O: · H2O: 20mg/mL, clear
InChI
InChI=1S/C15H22N2O.ClH/c1-11-7-6-8-12(2)14(11)16-15(18)13-9-4-5-10-17(13)3;/h6-8,13H,4-5,9-10H2,1-3H3,(H,16,18);1H

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 6 items

Danger

H301 (66.1%): Toxic if swallowed [Danger Acute toxicity, oral]

P264, P270, P273, P301+P316, P301+P317, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 62 reports by companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

Hazard information

Regulatory InformationMepivacaine hydrochloride: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Other Safety InformationIMAP assessments - 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-, monohydrochloride: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 3 (66.1%)

Toxicology

Treatment · 1 item

Treatment of a patient with toxic manifestations consists of assuring and maintaining a patient airway and supporting ventilation (respiration) as required. This usually will be sufficient in the management of most reactions. Should a convulsion persist despite ventilatory therapy, small increments of anticonvulsive agents may be given intravenously, such as benzodiazephine (e.g., diazepam) or ultrashort-acting barbiturates (e.g., thiopental or thiamylal) or short-acting barbiturates (e.g., pentobarbital or secobarbital). Cardiovascular depression may require circulatory assistance with intravenous fluids and/or vasopressor (e.g., Ephedrine) as dictated by the clinical situation. (L1712)

Chemistry & industry

Pharmacology

Metabolism/Metabolites · 1 item

Rapidly metabolized, with only a small percentage of the anesthetic (5 percent to 10 percent) being excreted unchanged in the urine. The liver is the principal site of metabolism, with over 50% of the administered dose being excreted into the bile as metabolites. Route of Elimination: It is rapidly metabolized, with only a small percentage of the anesthetic (5 percent to 10 percent) being excreted unchanged in the urine.The liver is the principal site of metabolism, with over 50% of the administered dose being excreted into the bile as metabolites. Half Life: The half-life of mepivacaine in adults is 1.9 to 3.2 hours and in neonates 8.7 to 9 hours.

FDA Pharmacological Classification · 4 items

MEPIVACAINE HYDROCHLORIDE

Amides [CS]; Amide Local Anesthetic [EPC]; Local Anesthesia [PE]

POLOCAINE (MEPIVACAINE HCL)

Amide Local Anesthetic [EPC]; Amides [CS]; Local Anesthesia [PE]

MeSH Pharmacological Classification · 1 item

Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate.

Uses & manufacturing

UsesFor production of local or regional analgesia and anesthesia by local infiltration, peripheral nerve block techniques, and central neural techniques including epidural and caudal blocks.
Use ClassificationAnimal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients

Related reactions

2 records
New reaction record
HRID 2273578 reaction equation
HRID 2273578As reactantuspto-grants-2015_09
HRID 2273579 reaction equation
HRID 2273579As reactantuspto-grants-2015_09

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
PubChem CID
66070
DTXSID
DTXSID4031566
ChEMBL
CHEMBL1200440
ChEBI
CHEBI:6760
UNII
4VFX2L7EM5
EC Number
217-023-9、691-388-6
InChIKey
RETIMRUQNCDCQB-UHFFFAOYSA-N
SMILES
C1(=C(C)C=CC=C1C)NC(=O)C1CCCCN1C.Cl
CAS DataBase Reference
1722 · 1722-62-9(CAS DataBase Reference)
FDA UNII
4 VFX2L7EM5 · 4VFX2L7EM5
NCI Drug Dictionary
mepivacaine hydrochloride
EPA Substance Registry System
2 · 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-, monohydrochloride (1722-62-9)
UNSPSC Code
41116107 · 41116107
NACRES
77 · NA.77
Symbol(GHS)
6 · GHS06
Signal word
Danger
Hazard statements
301 · H301-H336
Precautionary statements
261 · P261-P264-P270-P271-P301+P310-P304+P340+P312
target organs
Central nervous system
Hazard Codes
Xn
Risk Statements
22 · 22
Safety Statements
22 · 22-24/25
RIDADR
2811 · UN 2811 6.1 / PGIII
WGK Germany
3 · WGK 3
RTECS
6475000 · TK6475000
TSCA
TSCA listed
HS Code
29333990 · 29333990
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
3 OralSTOT · Acute Tox. 3 OralSTOT SE 3
Toxicity
50 in · LD50 in mice, rats (mg/kg): 280, 500 s.c. (Aberg)
Exposure Routes · 1 item

Absorbed locally. The rate of systemic absorption of local anesthetics is dependent upon the total dose and concentration of drug administered, the route of administration, the vascularity of the administration site, and the presence or absence of epinephrine in the anesthetic solution. Subcutaneous, injection ; Infiltration

Toxicity Summary · 1 item

Local anesthetics block the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential. In general, the progression of anesthesia is related to the diameter, myelination, and conduction velocity of affected nerve fibers. Clinically, the order of loss of nerve function is as follows: pain, temperature, touch, proprioception, and skeletal muscle tone.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Mepivacaine hydrochloride

vLess-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
Toxicity DataThe mean seizure dosage of mepivacaine in rhesus monkeys was found to be 18.8 mg/kg with mean arterial plasma concentration of 24.4 µg/mL. LD50: 23-35 mg/kg (Intravenous, Mouse) (A308) LD50: 280 mg/kg (Subcutaneous, Mouse (A308)

Safety data

wgk
WGK 3
tsca
TSCA listed
rtecs
TK6475000
ridadr
UN 2811 6.1 / PGIII
hs_code
29333990
Toxicity
LD50 in mice, rats (mg/kg): 280, 500 s.c. (Aberg)
risk_code
22
Signal word
Danger
Symbol(GHS)
GHS06
hazard_code
Xn
safety_code
22-24/25
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
target organs
Central nervous system
Hazard statements
H301-H336
Hazard Classifications
Acute Tox. 3 OralSTOT SE 3
Precautionary statements
P261-P264-P270-P271-P301+P310-P304+P340+P312
General Manufacturing Information
2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-, hydrochloride (1:1): ACTIVE
Applications · 4 items

Usesanesthetic (local)

UsesMepivacaine hydrochloride may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations by chromatography.

UsesAn anti-inflammatory and analgesic

General DescriptionPharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Mepivacaine hydrochloride is a local anesthetic that is related chemically and pharmacologically to the amide-type local anesthetics. It is often administered via local infiltration, peripheral nerve block, etc.

Upstream & downstream products

Downstream products

2-[[(2,6-Di(Methyl-d3)phenyl)aMino]carbonyl]-1,1-diMethyl-piperidiniuM Iodide

Suppliers101 total

国药集团化学试剂有限公司86-21-63210123 · [email protected]
北京华美互利生物化工010-56205725 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
济南诚汇双达生物有限公司053158897070 15550412551 · [email protected]
HubeiwidelychemicaltechnologyCo.,Ltd18627774460 · [email protected]
成都彼样生物科技有限公司18108052721 · [email protected]
合肥翰刚医药科技有限公司+8618062405514 · [email protected]
广州隽沐生物科技股份有限公司020-36607679; 13502246435 · [email protected]
上海遐瑞医药科技有限公司+86-021-61551413 · [email protected]
河北展药生物科技有限公司15369953316 +8615369953316 · [email protected]
Baoji Guokang Healthchem co.,ltd+8615604608665 15604608665 · [email protected]
Hebei Henghe Import and Export Trading Co. LTD+8618032935937 18032916000 · [email protected]
Dayang Chem (Hangzhou) Co.,Ltd.+86-0571-88938639 17705817739 · [email protected]
河北秒变生物科技有限公司17733850068
上海辅欣医药科技有限公司+86-021-021-50872116 · [email protected]
上海恩诺生物科技有限公司+86 (21) 6435-5022
上海瀚鸿科技股份有限公司021-54306202 13764082696 · [email protected]
南京圣亿来化工有限公司19951936396 · [email protected]
河北缤享新材料科技有限公司+8618633865755 · [email protected]
西安泽邦生物科技有限公司[email protected]
天津万象恒远科技有限公司15722085254 · [email protected]
上海景颜化工科技有限公司13817811078 · [email protected]
Pure Chemistry Scientific Inc.001-857-928-2050 or 1-888-588-9418 · [email protected]
上海泰坦科技股份有限公司4006009262 13023226327 · [email protected]
MedChemexpress LLC021-58955995 · [email protected]
武汉丰泰威远科技有限公司+86-27-8746-5837 +86-18627785180 · [email protected]
武汉丰泰威远科技有限公司027-87465837 19945049750 · [email protected]
云南西力生物技术股份有限公司0871-65217109 · [email protected]
Xiamen AmoyChem Co., Ltd+86-86-5926051114 · [email protected]
Hebei Qige Biological Technology Co. Ltd+86 +8618733132031
Wuhan Demeikai Biotechnology Co., Ltd+8618942921723 · [email protected]
斯百全化学(上海)有限公司021-021-021-67601398-809-809-809 15221380277 · [email protected]
Wuhan NCE Biomedical Co.,Ltd.4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
上海遐瑞医药科技有限公司+86 21 61551611
TCI AMERICA800-4238616 · [email protected]
TOKYO CHEMICAL INDUSTRY CO., LTD.03-36680489 · [email protected]
TCI Europe320-37350700 · [email protected]
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
上海诺宝化工有限公司+86(0)21 60484900
广州爱纯医药科技有限公司020-39119399 18927568969 · [email protected]
南京生利德生物科技有限公司025-57798810 18652991625 · [email protected]
湖北鑫源顺医药化工有限公司13971561712, 13995564702, 027-50664929 · [email protected]
上海寰川实业有限公司021-61478794 · [email protected]
凯试(上海)科技有限公司021-50135380 · [email protected]
Sigma-Aldrich西格玛奥德里奇(上海)贸易有限公司021-61415566 800-8193336 · [email protected]
南京伶亚生物医药科技有限公司18068075658 · [email protected]
江苏倍达医药科技有限公司0512-63009836 18994340901 · [email protected]
TargetMol中国(陶术生物)021-021-33632979 15002134094 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]

Additional notes

DefinitionChEBI: The hydrochloride salt of mepivacaine. It is used as a local anaesthetic.